Aptose to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease Companies Sep 16, 2019 7:30am EDT
Aptose Biosciences to Present at Canaccord Genuity 39th Annual Growth Conference Jul 30, 2019 7:30am EDT
Aptose To Release Second Quarter Ended June 30, 2019 Financial Results and Hold Conference Call on August 6, 2019 Jul 23, 2019 7:30am EDT
Aptose Doses First CLL Patient in Phase 1 Study of CG-806 and Doses Third Cohort in Phase 1 Study of APTO-253 Jul 16, 2019 7:05am EDT
Aptose Presents New Preclinical Data for CG-806 at the 24th Congress of the European Hematology Association Jun 14, 2019 7:00am EDT
Aptose Biosciences Announces Results of Annual and Special Meeting of Shareholders Jun 04, 2019 4:02pm EDT
